Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;280(7):3065-3074.
doi: 10.1007/s00405-023-07881-6. Epub 2023 Feb 15.

Surgical treatment of laryngeal amyloidosis: a systematic review

Affiliations

Surgical treatment of laryngeal amyloidosis: a systematic review

Francesca Galluzzi et al. Eur Arch Otorhinolaryngol. 2023 Jul.

Abstract

Purpose: The aim of this review was to study the surgical management of laryngeal amyloidosis and estimate the rate of recurrence after surgery.

Methods: A systematic review searching PubMed and EMBASE was performed. A qualitative synthesis of data regarding the surgical management of LA and a quantitative analysis of the recurrence rate after surgery was conducted.

Results: This systematic review included 14 retrospective studies, one of whom is retrospective controlled. A total of 515 subjects were included, the mean age ranged from 43.3 to 58 years with a male-to-female ratio of 1:1.3. All cases had a localized laryngeal amyloidosis. The supraglottic region was the most affected laryngeal site and multiple sites were commonly involved. Surgical treatment consists of endoscopic excision using laser, cold or powered instruments. Open surgery is required for severe primary case or revision surgery. Surgical complications such as granulomatosis scar tissue formation, tracheostomy, laryngotracheal stenosis, pneumothorax and concomitant malignancy were developed in 17.5% of patients. The time onset to diagnosis varied from 1 months to 15 years and the duration of follow-up from 3 months to 25 years. The rate of recurrence was 28.4% (95% CI 24.5-32.6) and the timing of recurrences ranged from 3 months to 10 years.

Conclusion: The recurrence rate after primary surgery for laryngeal amyloidosis is high. A tailored surgical treatment based on the disease extension and a long-term follow up are recommended.

Keywords: Amyloid; Laryngeal amyloidosis; Larynx; Recurrence; Surgery; Surgical treatment.

PubMed Disclaimer

Similar articles

  • Surgery for trigger finger.
    Fiorini HJ, Tamaoki MJ, Lenza M, Gomes Dos Santos JB, Faloppa F, Belloti JC. Fiorini HJ, et al. Cochrane Database Syst Rev. 2018 Feb 20;2(2):CD009860. doi: 10.1002/14651858.CD009860.pub2. Cochrane Database Syst Rev. 2018. PMID: 29460276 Free PMC article.
  • Conjunctival autograft for pterygium.
    Clearfield E, Muthappan V, Wang X, Kuo IC. Clearfield E, et al. Cochrane Database Syst Rev. 2016 Feb 11;2(2):CD011349. doi: 10.1002/14651858.CD011349.pub2. Cochrane Database Syst Rev. 2016. PMID: 26867004 Free PMC article.
  • Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
    Weibel S, Rücker G, Eberhart LH, Pace NL, Hartl HM, Jordan OL, Mayer D, Riemer M, Schaefer MS, Raj D, Backhaus I, Helf A, Schlesinger T, Kienbaum P, Kranke P. Weibel S, et al. Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
  • Systemic treatments for eczema: a network meta-analysis.
    Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, Lai NM, Dellavalle R, Chaiyakunapruk N. Sawangjit R, et al. Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206. doi: 10.1002/14651858.CD013206.pub2. Cochrane Database Syst Rev. 2020. PMID: 32927498 Free PMC article.
  • Localized laryngeal amyloidosis: A systematic review.
    Pai KK, Omiunu AO, Llerena PA, Shave SM, Desai HA, Fang CH, Eloy JA, Young VN. Pai KK, et al. Am J Otolaryngol. 2022 Sep-Oct;43(5):103550. doi: 10.1016/j.amjoto.2022.103550. Epub 2022 Jul 28. Am J Otolaryngol. 2022. PMID: 35917657

Cited by

References

    1. Stevenson R, Witteles R, Damrose E et al (2012) More than a frog in the throat: a case series and review of localized laryngeal amyloidosis. Arch Otolaryngol Head Neck Surg 138:509. https://doi.org/10.1001/archoto.2012.423 - DOI - PubMed
    1. Burns H, Phillips N (2019) Laryngeal amyloidosis. Curr Opin Otolaryngol Head Neck Surg 27:467–474. https://doi.org/10.1097/MOO.0000000000000579 - DOI - PubMed
    1. Mahmood S, Bridoux F, Venner CP et al (2015) Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study. Lancet Haematol 2:e241–e250. https://doi.org/10.1016/S2352-3026(15)00068-X - DOI - PubMed
    1. Rudy SF, Jeffery CC, Damrose EJ (2018) Clinical characteristics of laryngeal versus nonlaryngeal amyloidosis: characteristics of laryngeal amyloidosis. Laryngoscope 128:670–674. https://doi.org/10.1002/lary.26846 - DOI - PubMed
    1. Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387:2641–2654. https://doi.org/10.1016/S0140-6736(15)01274-X - DOI - PubMed

Publication types

LinkOut - more resources